| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 66 | 2025 | 1140 | 5.360 |
Why?
|
| CpG Islands | 37 | 2025 | 347 | 3.140 |
Why?
|
| Epigenesis, Genetic | 22 | 2025 | 767 | 2.950 |
Why?
|
| Colorectal Neoplasms | 17 | 2025 | 639 | 2.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2024 | 118 | 1.780 |
Why?
|
| Carcinogenesis | 4 | 2024 | 361 | 1.570 |
Why?
|
| Colonic Neoplasms | 9 | 2023 | 260 | 1.290 |
Why?
|
| Gene Silencing | 13 | 2012 | 246 | 0.890 |
Why?
|
| Promoter Regions, Genetic | 17 | 2015 | 1420 | 0.880 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2025 | 2125 | 0.870 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 37 | 0.840 |
Why?
|
| DNA | 5 | 2021 | 1676 | 0.700 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 177 | 0.590 |
Why?
|
| Microbiota | 2 | 2021 | 442 | 0.570 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 637 | 0.510 |
Why?
|
| Polymerase Chain Reaction | 10 | 2009 | 1582 | 0.510 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 2145 | 0.480 |
Why?
|
| Cell Differentiation | 6 | 2015 | 2026 | 0.460 |
Why?
|
| Mutation | 11 | 2017 | 6343 | 0.440 |
Why?
|
| Microsatellite Repeats | 6 | 2011 | 238 | 0.420 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2009 | 128 | 0.410 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 500 | 0.410 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 822 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 1067 | 0.410 |
Why?
|
| Nuclear Proteins | 9 | 2012 | 1341 | 0.410 |
Why?
|
| Mice | 18 | 2024 | 18935 | 0.400 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2009 | 502 | 0.390 |
Why?
|
| Intestinal Mucosa | 6 | 2015 | 791 | 0.370 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1692 | 0.370 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 1051 | 0.360 |
Why?
|
| Intestines | 1 | 2015 | 599 | 0.360 |
Why?
|
| Cell Line, Tumor | 21 | 2014 | 3794 | 0.340 |
Why?
|
| Stem Cells | 1 | 2015 | 748 | 0.330 |
Why?
|
| Neoplasm Proteins | 6 | 2009 | 712 | 0.320 |
Why?
|
| Gene Expression Profiling | 8 | 2010 | 1915 | 0.300 |
Why?
|
| Humans | 70 | 2025 | 133269 | 0.300 |
Why?
|
| DNA, Neoplasm | 8 | 2009 | 301 | 0.290 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 4 | 2015 | 158 | 0.290 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 1757 | 0.290 |
Why?
|
| DNA Modification Methylases | 4 | 2021 | 52 | 0.280 |
Why?
|
| Azacitidine | 6 | 2009 | 52 | 0.280 |
Why?
|
| Animals | 19 | 2024 | 36215 | 0.270 |
Why?
|
| Fluorouracil | 1 | 2007 | 141 | 0.270 |
Why?
|
| Folic Acid | 3 | 2024 | 291 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2021 | 624 | 0.270 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 1558 | 0.260 |
Why?
|
| Neoplasms | 9 | 2021 | 2989 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2009 | 788 | 0.260 |
Why?
|
| Colon | 5 | 2010 | 373 | 0.260 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2005 | 19 | 0.260 |
Why?
|
| Histones | 7 | 2021 | 572 | 0.250 |
Why?
|
| Aged | 22 | 2025 | 21479 | 0.250 |
Why?
|
| Temperature | 1 | 2007 | 326 | 0.250 |
Why?
|
| Long Interspersed Nucleotide Elements | 4 | 2010 | 37 | 0.240 |
Why?
|
| Adenoma | 4 | 2010 | 133 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1406 | 0.230 |
Why?
|
| Middle Aged | 27 | 2025 | 28952 | 0.230 |
Why?
|
| Male | 37 | 2025 | 65527 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2651 | 0.220 |
Why?
|
| Genomic Structural Variation | 1 | 2025 | 92 | 0.220 |
Why?
|
| Melanoma | 2 | 2009 | 953 | 0.210 |
Why?
|
| Genome, Human | 4 | 2011 | 1340 | 0.210 |
Why?
|
| Sulfites | 4 | 2014 | 31 | 0.210 |
Why?
|
| Female | 35 | 2025 | 71454 | 0.210 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 818 | 0.200 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 12 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 7 | 2014 | 1830 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 460 | 0.200 |
Why?
|
| Age of Onset | 1 | 2025 | 627 | 0.200 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 31 | 0.200 |
Why?
|
| Lysine | 4 | 2008 | 207 | 0.200 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 90 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 829 | 0.200 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2002 | 68 | 0.190 |
Why?
|
| Cyclins | 1 | 2002 | 105 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2010 | 1849 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 129 | 0.190 |
Why?
|
| Epigenomics | 2 | 2021 | 196 | 0.180 |
Why?
|
| Cohort Studies | 3 | 2025 | 5199 | 0.180 |
Why?
|
| Liver | 1 | 2009 | 1859 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2009 | 1001 | 0.180 |
Why?
|
| Adult | 18 | 2025 | 31648 | 0.180 |
Why?
|
| Diet | 2 | 2024 | 1170 | 0.170 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2007 | 197 | 0.170 |
Why?
|
| Aging | 3 | 2017 | 1280 | 0.170 |
Why?
|
| Cell Cycle | 1 | 2003 | 619 | 0.170 |
Why?
|
| Genome | 2 | 2021 | 528 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2012 | 8 | 0.160 |
Why?
|
| Dysbiosis | 1 | 2021 | 145 | 0.160 |
Why?
|
| Environmental Exposure | 1 | 2002 | 236 | 0.160 |
Why?
|
| Infant Nutrition Disorders | 1 | 2019 | 28 | 0.160 |
Why?
|
| Celiac Disease | 1 | 2019 | 57 | 0.150 |
Why?
|
| Duodenum | 1 | 2019 | 97 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 700 | 0.140 |
Why?
|
| Cell Line | 5 | 2013 | 2853 | 0.140 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2015 | 25 | 0.140 |
Why?
|
| Base Sequence | 8 | 2011 | 3153 | 0.140 |
Why?
|
| Aged, 80 and over | 10 | 2012 | 7137 | 0.130 |
Why?
|
| Machine Learning | 1 | 2020 | 345 | 0.130 |
Why?
|
| Adenocarcinoma | 3 | 2009 | 1013 | 0.130 |
Why?
|
| Hedgehog Proteins | 2 | 2015 | 268 | 0.130 |
Why?
|
| Malnutrition | 1 | 2019 | 222 | 0.130 |
Why?
|
| Phenotype | 8 | 2010 | 4577 | 0.120 |
Why?
|
| Animals, Suckling | 1 | 2015 | 51 | 0.120 |
Why?
|
| Aurora Kinase C | 1 | 2015 | 2 | 0.120 |
Why?
|
| Liver Neoplasms | 3 | 2011 | 1408 | 0.110 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2010 | 541 | 0.110 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 33 | 0.110 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 87 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1325 | 0.110 |
Why?
|
| Methylation | 2 | 2013 | 232 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2007 | 216 | 0.110 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2013 | 38 | 0.100 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 57 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2010 | 571 | 0.100 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 24 | 0.100 |
Why?
|
| Genes, Neoplasm | 3 | 2008 | 90 | 0.100 |
Why?
|
| Rectum | 2 | 2010 | 113 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 433 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2010 | 1097 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 631 | 0.100 |
Why?
|
| Chromatin | 3 | 2021 | 617 | 0.100 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 1118 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2013 | 223 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2010 | 439 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2559 | 0.090 |
Why?
|
| Algorithms | 2 | 2020 | 1731 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 373 | 0.090 |
Why?
|
| DNA Repair Enzymes | 2 | 2008 | 45 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2877 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 91 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2855 | 0.090 |
Why?
|
| Retinoblastoma Protein | 2 | 2008 | 85 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 231 | 0.080 |
Why?
|
| Retroelements | 1 | 2010 | 41 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2007 | 72 | 0.080 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 201 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 3960 | 0.080 |
Why?
|
| Apoptosis | 2 | 2007 | 1928 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2013 | 872 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 50 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2009 | 965 | 0.080 |
Why?
|
| DNA Primers | 5 | 2010 | 656 | 0.080 |
Why?
|
| Hydroxamic Acids | 2 | 2007 | 65 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 123 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2009 | 77 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1557 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 33 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3416 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 134 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 189 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2010 | 363 | 0.080 |
Why?
|
| Butyrates | 1 | 2009 | 42 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 293 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 4823 | 0.080 |
Why?
|
| Sp3 Transcription Factor | 1 | 2008 | 7 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 1364 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 45 | 0.070 |
Why?
|
| Genes, APC | 1 | 2008 | 12 | 0.070 |
Why?
|
| Centrosome | 1 | 2008 | 22 | 0.070 |
Why?
|
| ras Proteins | 2 | 2008 | 146 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 81 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 294 | 0.070 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2009 | 93 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 964 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 814 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2008 | 177 | 0.070 |
Why?
|
| Colitis | 1 | 2010 | 164 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 61 | 0.070 |
Why?
|
| Tumor Protein p73 | 1 | 2007 | 27 | 0.070 |
Why?
|
| Prostate | 2 | 2008 | 448 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2017 | 4918 | 0.070 |
Why?
|
| Drug Tolerance | 1 | 2007 | 40 | 0.070 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 2762 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2012 | 2720 | 0.070 |
Why?
|
| Leucovorin | 1 | 2007 | 54 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 111 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 2138 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2006 | 11 | 0.070 |
Why?
|
| Survival Rate | 2 | 2009 | 2207 | 0.070 |
Why?
|
| Sulfates | 1 | 2007 | 36 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 606 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 176 | 0.070 |
Why?
|
| Multigene Family | 1 | 2007 | 321 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 829 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 130 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 186 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 258 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 254 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3363 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 4 | 2008 | 52 | 0.060 |
Why?
|
| Cisplatin | 1 | 2007 | 286 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2007 | 372 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 714 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2006 | 45 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 103 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 39 | 0.060 |
Why?
|
| Adolescent | 6 | 2025 | 20547 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2007 | 1136 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2006 | 302 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1213 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2010 | 238 | 0.060 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 19 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2008 | 1606 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 1864 | 0.060 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2024 | 65 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 297 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 213 | 0.050 |
Why?
|
| Germ Cells | 1 | 2025 | 203 | 0.050 |
Why?
|
| Child | 5 | 2025 | 25843 | 0.050 |
Why?
|
| Genes, ras | 2 | 2017 | 101 | 0.050 |
Why?
|
| Telomerase | 1 | 2024 | 169 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 496 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 13 | 0.050 |
Why?
|
| Genes, p53 | 3 | 2009 | 226 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2010 | 945 | 0.050 |
Why?
|
| Disease Progression | 4 | 2014 | 2246 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 94 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 218 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2025 | 368 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 91 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 218 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2009 | 13099 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 899 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 88 | 0.050 |
Why?
|
| Aflatoxins | 1 | 2002 | 3 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 543 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 139 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 146 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2008 | 625 | 0.050 |
Why?
|
| Hepatitis | 1 | 2002 | 57 | 0.050 |
Why?
|
| Carcinogens | 1 | 2002 | 135 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2006 | 736 | 0.050 |
Why?
|
| Risk Factors | 3 | 2009 | 10954 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 55 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 893 | 0.050 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 36 | 0.050 |
Why?
|
| Prognosis | 3 | 2010 | 5042 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2021 | 228 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 163 | 0.040 |
Why?
|
| Fibrosis | 1 | 2002 | 428 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 2 | 2010 | 80 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 739 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 841 | 0.040 |
Why?
|
| Pakistan | 1 | 2019 | 95 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1584 | 0.040 |
Why?
|
| Growth | 1 | 2019 | 106 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2025 | 14859 | 0.040 |
Why?
|
| Colonic Polyps | 2 | 2010 | 73 | 0.040 |
Why?
|
| Young Adult | 2 | 2010 | 9917 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 734 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 250 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 504 | 0.040 |
Why?
|
| LIM Domain Proteins | 2 | 2008 | 64 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 3719 | 0.030 |
Why?
|
| Karyotyping | 2 | 2008 | 321 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2019 | 225 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2019 | 328 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2008 | 225 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2009 | 3417 | 0.030 |
Why?
|
| RNA, Untranslated | 2 | 2009 | 120 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2009 | 222 | 0.030 |
Why?
|
| Infant | 3 | 2019 | 13230 | 0.030 |
Why?
|
| HCT116 Cells | 2 | 2007 | 63 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1661 | 0.030 |
Why?
|
| Acetylation | 2 | 2008 | 196 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1202 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2007 | 1072 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 478 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 5439 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 28 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 757 | 0.030 |
Why?
|
| RNA, Long Noncoding | 2 | 2009 | 248 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 584 | 0.030 |
Why?
|
| Texas | 1 | 2002 | 3664 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 156 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 2952 | 0.030 |
Why?
|
| Genomics | 2 | 2014 | 1677 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 231 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1770 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 3043 | 0.020 |
Why?
|
| Time Factors | 1 | 2003 | 6544 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 910 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 34 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 2720 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2012 | 56 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2012 | 65 | 0.020 |
Why?
|
| Gambia | 1 | 2010 | 29 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2010 | 1611 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 344 | 0.020 |
Why?
|
| Fertilization | 1 | 2010 | 45 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 88 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 128 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 235 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 54 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1041 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2010 | 59 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 108 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 114 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 37 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 59 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 124 | 0.020 |
Why?
|
| Seasons | 1 | 2010 | 327 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 293 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 34 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 96 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 327 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 165 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 69 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2008 | 29 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 125 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2008 | 48 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 280 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 103 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2008 | 69 | 0.020 |
Why?
|
| Urothelium | 1 | 2008 | 60 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 180 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 384 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 579 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2009 | 200 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 146 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 231 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2008 | 83 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 753 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 35 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 131 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 13 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 606 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 484 | 0.020 |
Why?
|
| Remission Induction | 1 | 2007 | 307 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 100 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1033 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2007 | 26 | 0.020 |
Why?
|
| Friedreich Ataxia | 1 | 2007 | 48 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 191 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 233 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 252 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4758 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 134 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 227 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2006 | 45 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2007 | 111 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 362 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 348 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 805 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2006 | 7 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 93 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 289 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8628 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 459 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 83 | 0.020 |
Why?
|
| Cadherins | 1 | 2007 | 183 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 398 | 0.020 |
Why?
|
| Quinazolines | 1 | 2006 | 185 | 0.010 |
Why?
|
| Mesoderm | 1 | 2006 | 113 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 787 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 449 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 809 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 721 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 1378 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2009 | 488 | 0.010 |
Why?
|
| Leukemia | 1 | 2008 | 374 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 415 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 887 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1469 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 622 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 606 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1965 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1147 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 944 | 0.010 |
Why?
|
| DNA Repair | 1 | 2007 | 573 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 2050 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 624 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 445 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 1184 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1714 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 3131 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1433 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1730 | 0.010 |
Why?
|
| Palliative Care | 1 | 2006 | 465 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 3851 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 932 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1152 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6582 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 2165 | 0.010 |
Why?
|